Science & Technology Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Science & Technology Watch.

Press releases published on September 30, 2026

Sep. 30, 2026

Triboelectric Attenuation Induced by Lubricant Aging and Its Application in Oil Condition Monitoring

Indeterminate EIN Presswire

Sep. 30, 2026

WISeKey Reports First Half 2026 Financial Results, Accelerates Quantum and Post-Quantum Strategy and Provides Outlook

Indeterminate GlobeNewswire

Sep. 30, 2026

Werfen a 17. MTHT Kongresszuson mutatja be Magyarországon az ACL TOP Family 70 Series hemosztázis rendszereket

Indeterminate EIN Presswire

Sep. 30, 2026

Blaize Announces Restructuring Plan to Focus Resources on Core Growth Areas

Indeterminate GlobeNewswire

Sep. 30, 2026

TAPI (Technology & API Services) Names Serge Rogasik CEO to lead next chapter of growth and competitiveness

Indeterminate GlobeNewswire

Sep. 30, 2026

Tevogen Regains Compliance with Nasdaq Global Market Continued Listing Requirements

Indeterminate GlobeNewswire

Sep. 30, 2026

Richardson Electronics Announces Date of First Quarter Fiscal Year 2027 Conference Call

Indeterminate GlobeNewswire

Sep. 30, 2026

Pliant Therapeutics Appoints David Raben, M.D., as Chief Medical Officer

Indeterminate GlobeNewswire

Sep. 30, 2026

Lithium Argentina Announces Cauchari-Olaroz Stage 2 Scoping Study Results and Acceleration of Initial Phase of 10,000 tpa

Indeterminate GlobeNewswire

Sep. 30, 2026

Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026

Indeterminate GlobeNewswire

Sep. 30, 2026

Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026

Indeterminate GlobeNewswire

Sep. 30, 2026

ACM Research Announces Participation in 18th Annual CEO Investor Summit 2026

Indeterminate GlobeNewswire

Sep. 30, 2026

Progress Software Reports Fiscal Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Sep. 30, 2026

Longeveron to Participate in Three Longevity/Aging Investment Conferences

Indeterminate GlobeNewswire

Sep. 30, 2026

Atsena Presents Positive 18-Month Results from Part A of the Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis

Indeterminate GlobeNewswire

Sep. 30, 2026

Corvus Pharmaceuticals Announces Initiation of Phase 1b Clinical Trial of Soquelitinib for Patients with Hidradenitis Suppurativa

Indeterminate GlobeNewswire

Sep. 30, 2026

FormFactor Announces Participation in 18th Annual CEO Investor Summit 2026

Indeterminate GlobeNewswire

Sep. 30, 2026

Micron Technology, Inc. Reports Record Fiscal Fourth-Quarter and Full-Year 2026 Results

Indeterminate GlobeNewswire

Sep. 30, 2026

Monte Rosa Therapeutics to Present Results of MRT-8102 GFORCE-1 Phase 1 Study in Subjects with Elevated Cardiovascular Disease Risk

Indeterminate GlobeNewswire

Sep. 30, 2026

TTM Technologies, Inc. Completes Acquisition of Epiq Solutions, Enhancing TTM’s Strategic A&D Portfolio

Indeterminate GlobeNewswire